Discontinuation report LOTENSIN 20MG
Report ID | 23762 |
Drug Identification Number | 00885851 |
Brand name | LOTENSIN 20MG |
Common or Proper name | LOTENSIN 20MG 2 X 14 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BENAZEPRIL HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 2 X 14 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-03-30 |
Actual discontinuation date | 2018-08-28 |
Remaining supply date | 2018-03-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Lot expiring Sept 2018 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-27 | English | Compare |
v2 | 2017-09-27 | French | Compare |
v3 | 2018-08-28 | English | Compare |
v4 | 2018-08-28 | French | Compare |
v5 | 2018-08-28 | English | Compare |
v6 | 2018-08-28 | French | Compare |
v7 | 2018-08-29 | English | Compare |
Showing 1 to 7 of 7